Related Experiment Videos

[Current status of immunization against Haemophilus influenzae type b in children in Poland]

L Szenborn1, Z Rudkowski, E Saraczyńska

  • 1Poradni Szczepień SZO nad Matka i Dzieckiem we Wrocławiu.

Insights

Haemophilus influenzae type B (Hib) infections pose a significant risk to young children in Poland, with an estimated 29/100,000 incidence. Vaccination is crucial, and initial studies show Hib vaccines are safe and effective for infants.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Public health

Context:

  • Haemophilus influenzae type B (Hib) infections are a major concern in children under 5.
  • Poland faces an estimated 29/100,000 incidence of Hib infections, similar to the UK.
  • Annually, 425-850 invasive Hib infections, including purulent meningitis, occur in Poland.

Purpose:

  • To highlight the necessity of Haemophilus influenzae type B (Hib) immunization in Poland.
  • To present the initial findings on the safety of Hib vaccination in Polish infants.

Summary:

  • The study estimates Hib infection incidence in Polish children under 5 at 29/100,000.
  • An estimated 425-850 invasive Hib infections, particularly meningitis, occur yearly in Poland.
  • The first vaccination experience with TetractHib or ActHib in 368 infants demonstrated safety, aligning with international research.

Impact:

  • Emphasizes the critical need for widespread Hib vaccination programs in Poland.
  • Provides early evidence supporting the safety of Hib vaccines in infants, encouraging broader adoption.
  • Contributes to reducing the burden of invasive Hib diseases and meningitis in a vulnerable pediatric population.

Related Concept Videos